Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Eli Lilly and Company (LLY)

192.81   4.61 (2.45%) 05-06 08:10
Open: 188.65 Pre. Close: 188.2
High: 193.57 Low: 188.17
Volume: 4,242,994 Market Cap: 184,998M
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; and Sermonix Pharmaceuticals Inc., as well as an agreement with Junshi Biosciences to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 193.686 - 194.259 194.259 - 194.9
Low: 189.941 - 190.651 190.651 - 191.447
Close: 191.563 - 192.63 192.63 - 193.826

Technical analysis

as of: 2021-05-05 5:36:04 PM
Overall:       
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 226.09     One year: 264.07
Support: Support1: 184.31    Support2: 178.58
Resistance: Resistance1: 193.57    Resistance2: 226.09
Pivot: 186.93
Moving Average: MA(5): 186.38     MA(20): 185.92
MA(100): 188.85     MA(250): 166.29
MACD: MACD(12,26): -0.39     Signal(9): -1.19
Stochastic oscillator: %K(14,3): 69.53     %D(3): 50.21
RSI: RSI(14): 60.05
52-week: High: 218.00  Low: 129.21  Change(%): 26.0
Average Vol(K): 3-Month: 348543  10-Days: 349794

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
LLY has closed below upper band by 8.4%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 06 May 2021
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes - PRNewswire

Wed, 05 May 2021
Eli Lilly and Company (LLY) gains 2.45% for May 05 - Equities.com

Wed, 05 May 2021
Eli Lilly Under FDA Scrutiny At Its COVID-19 Drug Manufacturing Facilities Amid Staff Accusations: Reuters - Yahoo Finance

Wed, 05 May 2021
Should Drug Manufacturers - General Stock Eli Lilly And Co (LLY) Be in Your Portfolio Wednesday? - InvestorsObserver

Tue, 04 May 2021
Was The Smart Money Right About Eli Lilly and Company (LLY)? - Yahoo Finance

Mon, 03 May 2021
The Zacks Analyst Blog Highlights: Eli Lilly, Merck, GlaxoSmithKline, Novartis and Johnson & Johnson - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 959
Shares Float (M) 857
% Held by Insiders 0.15
% Held by Institutions 83.75
Shares Short (K) 6,380
Shares Short P. Month (K) 6,980

Stock Financials

EPS 6.680
EPS Est This Year 4.200
EPS Est Next Year 4.630
Book Value (p.s.) 6.220
Profit Margin 23.91
Operating Margin 30.35
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 16.1
Gross Profit (p.s.) 19.875
Sales Per Share 26.580
EBITDA (p.s.) 9.510
Qtrly Earnings Growth -6.90
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio 28.86
PEG Ratio
Price to Book value 31.00
Price to Sales 7.25
Price to Cash Flow

Stock Dividends

Dividend 3.070
Forward Dividend 3.400
Dividend Yield 0.02
Dividend Pay Date 2021-03-09
Ex-Dividend Date 2021-02-10
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.